Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lichen International (LICN) Cash & Equivalents (2021 - 2025)

Lichen International (LICN) has disclosed Cash & Equivalents for 4 consecutive years, with $26.7 million as the latest value for Q4 2024.

  • Quarterly Cash & Equivalents rose 3.31% to $26.7 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $26.7 million through Dec 2024, up 3.31% year-over-year, with the annual reading at $26.7 million for FY2024, 3.31% up from the prior year.
  • Cash & Equivalents for Q4 2024 was $26.7 million at Lichen International, up from $25.9 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $26.7 million in Q4 2024, with the low at $16.8 million in Q4 2021.
  • Average Cash & Equivalents over 4 years is $23.0 million, with a median of $24.2 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents skyrocketed 34.16% in 2022, then rose 3.31% in 2024.
  • Over 4 years, Cash & Equivalents stood at $16.8 million in 2021, then skyrocketed by 34.16% to $22.6 million in 2022, then increased by 14.41% to $25.9 million in 2023, then increased by 3.31% to $26.7 million in 2024.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $26.7 million, $25.9 million, and $22.6 million for Q4 2024, Q4 2023, and Q4 2022 respectively.